Community pneumonia - More help is needed to diagnose and assess severity

British Journal of General Practice

Volumn 52, Issue 484, 2002, Pages 886-888

  Melbye, Hasse ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNICABLE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPNEA; EDITORIAL; FATALITY; GENERAL PRACTICE; HUMAN; HYPOXEMIA; LOWER RESPIRATORY TRACT INFECTION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOPLASMA PNEUMONIAE; NORMAL VALUE; OXYGENATION; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROGNOSIS; PULSE OXIMETRY; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SYMPTOM; THORAX RADIOGRAPHY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; SENSITIVITY AND SPECIFICITY;

EID: 0036842810     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56 (Suppl 4): IV1-IV64.
2. Simpson JC, Macfarlane JT, Watson J, Woodhead MA. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory Service. Thorax 200; 55: 1040-1045.
3. Dorca J, Torres A. Lower respiratory tract infections in the community: towards a more rational approach. Eur Respir J 1996; 9: 1588-1589.
4. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest 2001; 119L: 1190-1209.
5. Melbye H, Berdal BP, Straume B, et al. Pneumonia - a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice. Scand J Infect Dis 1992; 24: 647-655.
6. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278: 1440-1445.
7. Diehr P, Wood RW, Bushyhead J, et al. Prediction of pneumonia in outpatients with acute cough - a statistical approach. J Chronic Dis 1984; 37: 215-225.
8. Melbye H, Straume B, Aasebo U, Dale K. Diagnosis of pneumonia in adults in general practice. Relative importance of typical symptoms and abnormal chest signs evaluated against a radiographic reference standard. Scand J Prim Health Care 1992; 10: 226-233.
9. Holmes WF, Macfarlane JT, Macfarlane RM, Hubbard R. Symptoms, signs, and prescribing for acute lower respiratory tract illness. Br J Gen Pract 2001; 51: 177-181.
10. Hedlund J, Hansson LO, Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis 1995; 27: 32-37.
11. Smith RP, Lipworth BJ. C-reactive protein in simple community-acquired pneumonia. Chest 1995; 107: 1028-1031.
12. Smith RP, Lipworth BJ, Cree IA, et al. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288-1291.
13. Melbye H, Straume B, Aasebo U, Brox J. The diagnosis of adult pneumonia in general practice. The diagnostic value of history, physical examination and some blood tests. Scand J Prim Health Care 1988; 6: 111-117.
14. Melbye H, Staume B, Brox J. Laboratory tests for pneumonia in general practice: the diagnostic values depend on the duration of illness. Scand J Prim Health Care 1992; 10: 234-240.
15. Lehtomaki K. Rapid etiological diagnosis of pneumonia in young men. Scand J Infect Dis Suppl 1988; 54: 1-56.
16. Putto A, Ruuskanen O, Meurman O, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Child 1986; 61: 24-29.
17. Ruuskanen O, Putto A, Sarkkinen H, et al. C-reactive protein in respiratory virus infections. J Pediatr 1985; 107: 97-100.
18. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982; 389: 406-418.
19. Ritland N, Melbye H. C-reactive protein, SR and white blood cell count in acute lower respiratory tract diseases. The usefulness of blood tests in diagnosis of pneumonia. [In Norwegian.] Tidsskr Nor Laegeforen 1991; 111: 2249-2252.
20. Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56: 109-114.
21. Syrjala H, Broas M, Suramo I, et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998; 27: 358-363.
22. Farr BM, Woodhead MA, Macfarlane JT, et al. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med 2000; 94: 422-427.
23. Levin KP, Hanusa BH, Rotondi A, et al. Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia. J Gen Intern Med 2001; 16: 590-598.